Pilot Trial Of An Indoleamine 2,3-Dioxygenase-1 (Ido1) Inhibitor Plus A Multipeptide Melanoma Vaccine In Patients With Advanced Melanoma.
JOURNAL OF CLINICAL ONCOLOGY(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2018)